The U.S. Food and Drug Administration in mid-July issued a draft guidance on the use of inks, pigments, flavors, and other physical-chemical identifiers (PCIDs) employed by manufacturers to make drug products more difficult to duplicate by counterfeiters and easier to authenticate.
The draft guidance is an important step in working with manufacturers to make drug products harder to counterfeit.The agency invites comments on the draft guidance, which is titled, “Draft Guidance for Industry: Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting.”




















